AI Meets Medicine: Strategies, Start-ups and Corporate Innovation
- Date: Thursday 6 February 2025, 09:30 – 14:30
- Location: Nexus, Discovery Way, Leeds, LS2 3AA
- Type: Ideas in Practice
- Cost: Free
Join our in-person event delving into the regulatory frameworks and adoption challenges shaping medical AI innovation.
Register your place on Eventbrite
The rapid rise of Artificial Intelligence (AI) as a Medical Device (AIaMD), particularly Generative AI, is reshaping the medical and biotechnology sectors. While these technologies promise groundbreaking advancements, they also present significant strategic and managerial challenges. Start-ups and large corporations alike must navigate an evolving landscape marked by regulatory complexities, uncertain market dynamics and the need for radical innovation.
Developing AI-powered medical solutions, such as generative diagnostics, autonomous clinical decision-making systems and AI-driven drug discovery, requires not only technological innovation but also effective entrepreneurial strategies and corporate innovation capabilities. Companies must balance product, service and business model innovations while managing regulatory compliance in a sector where health system complexity and stringent oversight play critical roles.
At this event, we will hear from industry leaders in AI-powered medical technology, regulators and academics from Leeds University Business School about the strategic challenges faced in commercialising AIaMD innovations.
Emerging research at Leeds University Business School shows that policy frameworks and regulations alone cannot fully stimulate AI innovation in medtech if managerial and innovation capabilities are not sufficiently developed. Academics and industry professionals will open discussion to solutions, including the exploration of effective integration of technological (AI) and medical expertise, as well as tailored communication of novel technologies to investors, customers and regulators.
AI Meets Medicine: Strategies, Start-ups and Corporate Innovation is aimed at industry professionals from medtech, biotech, pharma, medical supply firms, regulators, policymakers, and academic researchers interested in innovation and AI-driven transformation.
Event programme:
| 09:30 | Arrival and registration |
| 10:00 |
Welcome and introductions Krsto Pandza, Director of Research Impact and Professor of Strategy and Innovation at Leeds University Business School Hutan Ashrafian, Visiting Professor of Research Impact at Leeds University Business School, and Chief Scientific Officer of Flagship Pioneering’s Preemptive Medicine and Health Security Initiative |
| 10:10 |
Presentation 1 Umang Patel, Chief Clinical Officer at Microsoft |
| 10:25 |
Presentation 2 Simon Rasalingham, Chief Executive Officer and Chairman at Behold.ai |
| 10:40 |
Presentation 3 Krsto Pandza, Professor of Strategy and Innovation at Leeds University Business School |
| 10:55 |
Panel discussion 1 - From Vision to Execution: The Role of Leadership in Bringing Medtech Innovations to Life Moderated by Hutan Ashrafian, Leeds University Business School and Flagship Pioneering Umang Patel, Chief Clinical Officer, Microsoft Roberto Liddi, Vice President of Regulatory and Compliance, NuraLogix Thomas Pearson-Jones, Chief Operating Officer, Optellum (TBC) Krsto Pandza, Professor of Strategy and Innovation, Leeds University Business School |
| 11:40 | Refreshment break |
| 12:00 |
Presentation 4 Maciej Kardas, Commercial Manager at Optellum (TBC) |
| 12:15 |
Presentation 5 Johan Ordish, Head of Digital Health and Innovation Policy at Roche Diagnostics (TBC) |
| 12:30 |
Panel discussion 2 - Adopting AI Innovations in the Medtech Ecosystem Moderated by Hutan Ashrafian, Leeds University Business School and Flagship Pioneering Simon Rasalingham, Chief Executive Officer and Chairman, Behold.ai Rachel Dunscombe, Chief Executive Officer, openEHR International Dr Nisha Sharma, Clinical Advisor to NHS England, Leeds Teaching Hospitals NHS Trust Michael Nix, Principal Clinical Scientist, Leeds Teaching Hospitals NHS Trust Roberto Liddi, Vice President of Regulatory and Compliance, NuraLogix Johan Ordish, Head of Digital Health and Innovation Policy, Roche Diagnostics (TBC) |
| 13:15 |
Event roundup |
| 13:30 |
Networking lunch |
| 14:30 | Event close |
If you have any questions about this event, please contact Grace Carter at Leeds University Business School.